Recent advances in the diagnosis of multiple myeloma
4th International Conference on Blood Malignancies & Treatment
April 18-19, 2016 Dubai, UAE

Chhaya Rani Shevra

Maharani Laxmi Bai Medical College, India

Scientific Tracks Abstracts: J Blood Disord Transfus

Abstract:

Multiple myeloma (MM) is the most common primary bone malignancy. It accounts for 10% of all the hematological malignancies diagnosed in USA. More commonly seen in African Americans than in white persons, median age at diagnosis is 68 yrs in male and 70 yrs in female. �?? to �?? of patients present with bone pain. Vertebra, skull, ribs, sternum, proximal humeri, and femora bones are involved most frequently. Bone lesions occur due to uncoupling of balance between osteoclastic and osteoblastic activity. IL-1β, IL-6, TNF-a, and MIP-1a all activate osteoclastic activity. Among these cytokines, IL6 cytokine is important. It belongs to cytokine superfamily which includes leukemia inhibitory factor, oncostatin M, ciliary neurotrophic factor and IL11. In normal person, it is secreted mainly by TH2 cells, monocyte, macrophages, activated B cells and endothelial cells. It has synergistic action with IL1, TNFα and produces acute phase response, B cell proliferation and differentiation, immunoglobulin production and hematopoiesis. This cytokine is not only responsible for proliferation of MM cells but also produces destruction of bone. Contrary to it IL4, cytokine, secreted by TH2 cells have been found to be decreased in myeloma. In normal person, IL4 produces proliferation of TH2 cell, B cells, mast cell, eosinophil and isotype switching for IgE production. Hence, we can conclude that MM shows elevated IL6 and decreased IL4. In future, treatment with anti IL6 and recombinant IL4 can be tried to treat MM Patients.

Biography :

Chhaya Rani Shevra has completed Post-graduation from Institute of Medical Sciences, Banaras Hindu University in 2011. She was an Assistant Professor in the same university for 2 months. She is now working in MLB Medical College Jhansi and has published many papers in reputed journals.

Email: shevrachhaya@gmail.com